A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies
一项针对晚期实体恶性肿瘤患者的 LHC165 单药治疗及联合 spartalizumab 治疗的 I 期临床试验
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103643
Curigliano, G; Jimenez, M M; Shimizu, T; Keam, B; Meric-Bernstam, F; Rutten, A; Glaspy, J; Schuler, P J; Parikh, N S; Ising, M; Hassounah, N; Wu, J; Leyk, M; Chen, X; Burks, H; Chaudhury, A; Otero, J; Cabanas, E Garralda